https://www.selleckchem.com/Bcl-2.html
Patients with COVID-19 infection are at risk of acute respiratory disease syndrome (ARDS) and death. The tissue receptor for COVID-19 is ACE2, and higher levels of ACE2 can protect against ARDS. Angiotensin receptor blockers and statins upregulate ACE2. Clinical trials are needed to determine whether this drug combination might be used to treat patients with severe COVID-19 infection. Copyright © 2020 Fedson et al.While the benefits of regular participation in physical activity in children and young people are clear, misconceptions have developed
Like
Comment
Share
